Bipolar News

Antidepressants Alone: Not For Bipolar Depression

Mon, 23 Jun 2008 10:00:03 GMT

Psychiatrists have cautioned against the use of antidepressants alone in people with bipolar disorders, saying they could worsen a patient's condition by causing a destabilisation in mood.

Full text

Alcohol Dependence May Respond To Aripiprazole, Treatment For Bipolar Disorder And Schizophrenia.

Sun, 22 Jun 2008 06:40:04 GMT

* Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. * A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol.

Full text

Overview Of Asenapine Data From Olympia Trial Program Presented At American Psychiatric Association Annual Meeting

Sun, 22 Jun 2008 06:40:03 GMT

Schering-Plough Corporation (NYSE: SGP) announced that an overview of asenapine clinical trials from the Olympia program was presented at the 161st Annual Meeting of the American Psychiatric Association in Washington, D.

Full text

ACADIA Announces Presentation Of Data On Pimavanserin Co-Therapy At The 14th Biennial Winter Workshop On On Schizophrenia And Bipolar Disorders

Sat, 21 Jun 2008 03:20:29 GMT

ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that Murray Rosenthal, D.

Full text

Study Suggests Risperidone Long-Acting Injection Combined With Standard Treatment Helped Delay Time To Relapse In Patients With Bipolar Disorder

Sat, 21 Jun 2008 03:20:28 GMT

Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study.

Full text

Astrazeneca Submits Seroquel XR For The Treatment Of Bipolar Mania And Bipolar Depression, And Seroquel R For The Treatment Of Bipolar Depression

Sat, 21 Jun 2008 03:20:27 GMT

AstraZeneca announced that the company has submitted applications in the European Union (EU) under the Mutual Recognition Procedure (MRP) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, seeking approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

Full text

Bipolar Depression Licence Application For Seroquel R

Sat, 21 Jun 2008 03:20:27 GMT

AstraZeneca has submitted an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a new licence for Seroquel(R) (quetiapine fumarate) in the UK for major depressive episodes in the framework of bipolar disorder.

Full text

Alexza Initiates First Phase 3 Clinical Trial For AZ-004 Staccato R Loxapine

Sat, 21 Jun 2008 03:20:26 GMT

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated its first Phase 3 clinical trial with AZ-004 (Staccato(R) loxapine).

Full text

Indiana U Study May Alter Approach To Psychiatric Treatment

Sat, 21 Jun 2008 03:20:25 GMT

Indiana University School of Medicine researchers have isolated biomarkers in the blood that identify mood disorders, a breakthrough that may change the way bipolar illness is diagnosed and treated.

Full text

ABILIFY Approved For Acute Treatment Of Bipolar I Disorder In Patients 10 To 17 Years Old

Sat, 21 Jun 2008 03:20:24 GMT

Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.

Full text